Tofogliflozin, a sodium/glucose cotrasporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models - Suzuki, M; Takeda, M; Kito, A (Nutr Diabetes, 2014)
et al.